Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects

por Arm, J P, Bottoli, I, Skerjanec, A, Floch, D, Groenewegen, A, Maahs, S, Owen, C E, Jones, I, Lowe, P J
Publicado 2014